	US 12,070,498 B2
	Conjugate vaccine targeting a disease-causing biological protein
Hironori Nakagami, Suita (JP); Ryuichi Morishita, Suita (JP); and Akiko Tenma, Ibaraki (JP)
Assigned to OSAKA UNIVERSITY, Suita (JP); and FUNPEP CO., LTD., Ibaraki (JP)
Filed by OSAKA UNIVERSITY, Suita (JP); and FUNPEP CO., LTD., Ibaraki (JP)
Filed on Mar. 12, 2021, as Appl. No. 17/200,552.
Application 17/200,552 is a division of application No. 16/087,799, granted, now 10,980,876, previously published as PCT/JP2017/012187, filed on Mar. 24, 2017.
Claims priority of application No. 2016-062872 (JP), filed on Mar. 25, 2016.
Prior Publication US 2021/0205446 A1, Jul. 8, 2021
Int. Cl. A61K 39/395 (2006.01); A61K 39/00 (2006.01); A61K 39/39 (2006.01); A61P 37/04 (2006.01)

CPC A61K 39/39 (2013.01) [A61K 39/00 (2013.01); A61K 39/00114 (2018.08); A61K 39/39533 (2013.01); A61P 37/04 (2018.01); A61K 2039/55527 (2013.01)]

9 Claims

1. A vaccine comprising a complex of a peptide consisting of the amino acid sequence of SEQ ID NO: 1 and an epitope of a disease-causing A biological protein, wherein the biological protein is immunoglobulin E (IgE).